News

Knowledge guided cancer therapy is about to get a boost.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas ut fringilla ipsum. Donec congue quis dolor vel suscipit. Donec eu odio pretium, sodales leo non, maximus lectus. Sed eu mi non sem pulvinar tempus dictum sed risus. Donec rhoncus elementum nibh, nec aliquet enim gravida sit amet. Suspendisse iaculis varius libero, sit amet tempor dui […]

Knowledge guided cancer therapy is about to get a boost. Read More »

Matthew Groves presented Protyon at the MepAnti Drug Research Symposiu

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas ut fringilla ipsum. Donec congue quis dolor vel suscipit. Donec eu odio pretium, sodales leo non, maximus lectus. Sed eu mi non sem pulvinar tempus dictum sed risus. Donec rhoncus elementum nibh, nec aliquet enim gravida sit amet. Suspendisse iaculis varius libero, sit amet tempor dui

Matthew Groves presented Protyon at the MepAnti Drug Research Symposiu Read More »

Protyon on the voyage to the Czech Republic. Next station: conference Prague.bio

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas ut fringilla ipsum. Donec congue quis dolor vel suscipit. Donec eu odio pretium, sodales leo non, maximus lectus. Sed eu mi non sem pulvinar tempus dictum sed risus. Donec rhoncus elementum nibh, nec aliquet enim gravida sit amet. Suspendisse iaculis varius libero, sit amet tempor dui

Protyon on the voyage to the Czech Republic. Next station: conference Prague.bio Read More »

Protyon has been granted  the Rabo Innovation Loan to help bring its technology to the market.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas ut fringilla ipsum. Donec congue quis dolor vel suscipit. Donec eu odio pretium, sodales leo non, maximus lectus. Sed eu mi non sem pulvinar tempus dictum sed risus. Donec rhoncus elementum nibh, nec aliquet enim gravida sit amet. Suspendisse iaculis varius libero, sit amet tempor dui

Protyon has been granted  the Rabo Innovation Loan to help bring its technology to the market. Read More »

License agreement with RUG and UMCG for technology to improve the efficacy of cancer treatment.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas ut fringilla ipsum. Donec congue quis dolor vel suscipit. Donec eu odio pretium, sodales leo non, maximus lectus. Sed eu mi non sem pulvinar tempus dictum sed risus. Donec rhoncus elementum nibh, nec aliquet enim gravida sit amet. Suspendisse iaculis varius libero, sit amet tempor dui

License agreement with RUG and UMCG for technology to improve the efficacy of cancer treatment. Read More »

Etiam eleifend magna non nequeac sagittis enim rutrum lorsem feugiat ipsum.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas ut fringilla ipsum. Donec congue quis dolor vel suscipit. Donec eu odio pretium, sodales leo non, maximus lectus. Sed eu mi non sem pulvinar tempus dictum sed risus. Donec rhoncus elementum nibh, nec aliquet enim gravida sit amet. Suspendisse iaculis varius libero, sit amet tempor dui

Etiam eleifend magna non nequeac sagittis enim rutrum lorsem feugiat ipsum. Read More »

startups en gevestigde bedrijven slaan handen ineen

(Dutch) De samenwerkingen van de toekomst, de samenwerkingen mét de toekomst. De finale van de Groningen Open leverde donderdag weer mooie combinaties op tussen gevestigde bedrijven en startups. NNZ begint een samenwerking met BEBR, KroeseWevers slaat de handen ineen met LEF en ODE koos Nostics en Protyon uit. Multinational NNZ uit Groningen is marktleider op

startups en gevestigde bedrijven slaan handen ineen Read More »